COPD急性加重出院后3周内启动肺康复的疗效:系统综述与荟萃分析
结果显示肺康复可减少再入院(OR 0.48,95%CI 0.30–0.77),改善运动能力、健康相关生活质量和呼吸困难,未报告干预相关不良事件。
要点
- COPD急性加重出院后3周内启动肺康复可降低再入院风险(OR 0.48)。
- 肺康复改善6分钟步行距离(MD 57 m)和增量往返步行距离(MD 43 m)。
- 肺康复改善SGRQ评分(MD -8.7分)及CRQ情感、疲劳、呼吸困难维度。
核心结论
- COPD急性加重出院后启动肺康复可减少再入院并改善运动能力、健康相关生活质量和呼吸困难。
- 未报告干预相关不良事件。
研究设计与样本
- 对既往Cochrane综述的更新,检索Cochrane Airways Review Group Specialised Register。
- 采用通用逆方差随机效应方法生成森林图。
主要发现
- 再入院:OR 0.48(95%CI 0.30–0.77,I2=67%)。
- 6分钟步行试验:MD 57 m(95%CI 29–86,I2=89%)。
- 增量往返步行试验:MD 43 m(95%CI 6–79,I2=81%)。
- SGRQ:MD -8.7分(95%CI -12.5至-4.9,I2=59%);CRQ情感:MD 1.0分(95%CI 0.4–1.6,I2=74%);CRQ疲劳:MD 0.9分(95%CI 0.1–1.6,I2=91%)。
- CRQ呼吸困难:MD 1.0分(95%CI 0.3–1.7,I2=87%);mMRC:MD -0.3分(95%CI -0.5至-0.1,I2=60%)。
关键数值与推荐
- 肺康复需在COPD急性加重出院后3周内启动。
- CRQ掌握感、CAT、EQ-5D-5L及死亡率未观察到显著效应。
- 未报告干预相关不良事件。
临床怎么用
- 对COPD急性加重出院患者,可考虑在出院后3周内启动肺康复以降低再入院风险。
- 肺康复可改善运动能力和健康相关生活质量,并缓解呼吸困难。
局限性
- 部分结局异质性较高(如6分钟步行试验I2=89%、CRQ疲劳I2=91%)。
- CRQ掌握感、CAT、EQ-5D-5L及死亡率未见显著效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Previous systematic reviews have provided heterogeneous and differing estimates for the efficacy of pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease (COPD). The aim of this review was to examine the efficacy of pulmonary rehabilitation programmes initiated within 3 weeks of hospital discharge following an exacerbation of COPD. METHODS: An update of a previous Cochrane review was undertaken using the Cochrane Airways Review Group Specialised Register. Searches were conducted from October 2015 to August 2023 for studies that initiated pulmonary rehabilitation within 3 weeks of hospital discharge. Studies assessing the impact of solely inpatient pulmonary rehabilitation were excluded. Forest plots were generated using a generic inverse variance random effects method. RESULTS: Seventeen studies were included. Posthospital discharge pulmonary rehabilitation reduced hospital re-admissions (OR 0.48, 95% CI 0.30 to 0.77, I2=67%), improved exercise capacity (6 min walk test, mean difference (MD) 57 m, 95% CI 29 to 86, I2=89%; incremental shuttle walk test, MD 43 m, 95% CI 6 to 79, I2=81%), health-related quality of life (St. George's Respiratory Questionnaire, MD -8.7 points, 95% CI -12.5 to -4.9, I2=59%; Chronic Respiratory Disease Questionnaire (CRQ)-emotion, MD 1.0 points, 95% CI 0.4 to 1.6, I2=74%; CRQ-fatigue, MD 0.9 points, 95% CI 0.1 to 1.6, I2=91%), and dyspnoea (CRQ-dyspnoea, MD 1.0 points, 95% CI 0.3 to 1.7, I2=87%; modified Medical Research Council Dyspnoea Scale, MD -0.3 points, 95% CI -0.5 to -0.1, I2=60%). Significant effects were not observed for CRQ-mastery, COPD assessment test, EuroQol-5 Dimension-5 Level and mortality. No intervention-related adverse events were reported. DISCUSSION: Pulmonary rehabilitation delivered posthospital discharge for exacerbation of COPD results in a reduction in hospital re-admissions and improvements in exercise capacity, health-related quality of life and dyspnoea in the absence of any intervention-related adverse events. TRIAL REGISTRATION NUMBER: CRD42023406397.
引用
- Jenkins AR, Burtin C, Camp PG, et al. Do pulmonary rehabilitation programmes improve outcomes in patients with COPD posthospital discharge for exacerbation: a systematic review and meta-analysis. Thorax. 2024. PMID: 38350731. doi:10.1136/thorax-2023-220333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。